GENE ONLINE|News &
Opinion
Blog

Companion Diagnostic
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
FDA Okays Second FGFR Inhibitor for Cholangiocarcinoma, Approves FMI’s CGP Test as Companion Diagnostic
2021-05-31
10 Precision Oncology Companies to Look Out for
2021-05-27
R&D
Mirvie Heralds Liquid Biopsy-Based Test to Predict Pregnancy Complications
2021-04-28
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
Weekly in Asia|Oct-1
2019-10-14
Weekly in Asia 20190602-0608
2019-06-11
A competition for cancer cells and human medical testing – How to use liquid biopsy to break through the testing dilemma?
2018-10-11
Latest Developments in Precision Medicine and Molecular Detection
2018-09-19
“Project Oxygen”of Precision Medicine Exclusive Interview of Dr. Chris Tsai, Founder of Bionet
2017-08-07
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
EVENT
Scroll to Top